Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial

BACKGROUND: A vaccine against SARS-CoV-2 for children and adolescents will play an important role in curbing the COVID-19 pandemic. Here we aimed to assess the safety, tolerability, and immunogenicity of a candidate COVID-19 vaccine, CoronaVac, containing inactivated SARS-CoV-2, in children and adol...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Bihua, Song, Yufei, Li, Changgui, Yang, Wanqi, Ma, Qingxia, Jiang, Zhiwei, Li, Minjie, Lian, Xiaojuan, Jiao, Wenbin, Wang, Lei, Shu, Qun, Wu, Zhiwei, Zhao, Yuliang, Li, Qi, Gao, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238449/
https://www.ncbi.nlm.nih.gov/pubmed/34197764
http://dx.doi.org/10.1016/S1473-3099(21)00319-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238449/
https://www.ncbi.nlm.nih.gov/pubmed/34197764
http://dx.doi.org/10.1016/S1473-3099(21)00319-4

Ejemplares similares